Search
On the opening day of the CIIE, Meituan Healthcare joined forces with more than ten globally renowned pharmaceutical companies—including AstraZeneca, Pfizer, and Eisai—as well as Top 100 chain pharmacies such as Yifeng and Dashenlin to jointly establish the "New Specialty Drug Debut Alliance." Under this tripartite collaboration model of "pharma companies + platform + chain pharmacies," multiple leading chains will open green channels for innovative drugs, cutting the cycle from in-store arrival to instant retail to as fast as under 30 days. Moving forward, all parties will continue to deepen the development of the innovative drug debut network, enhance supply coordination efficiency during drug launch periods, and help global innovative drugs reach Chinese households' "15-minute living circle" more quickly.
-
C114 Communication Network -
Communication Home
